Knockout of the erythromycin biosynthetic cluster gene, eryBI, blocks isoflavone glucoside bioconversion during erythromycin fermentations in Aeromicrobium erythreum but not in Saccharopolyspora erythraea.
Isoflavone glucosides are valuable nutraceutical compounds and are present in commercial fermentations, such as the erythromycin fermentation, as constituents of the soy flour in the growth medium. The purpose of this study was to develop a method for recovery of the isoflavone glucosides as value-added coproducts at the end of either Saccharopolyspora erythraea or Aeromicrobium erythreum fermentation. Because the first step in isoflavone metabolism was known to be the conversion of isoflavone glucosides to aglycones by a beta-glucosidase, we chose to knock out the only beta-glucosidase gene known at the start of the study, eryBI, to see what effect this had on metabolism of isoflavone glucosides in each organism. In the unicellular erythromycin producer A. erythreum, knockout of eryBI was sufficient to block the conversion of isoflavone glucosides to aglycones. In S. erythraea, knockout of eryBI had no effect on this reaction, suggesting that other beta-glucosidases are present. Erythromycin production was not significantly affected in either strain as a result of the eryBI knockout. This study showed that isoflavone metabolism could be blocked in A. erythreum by eryBI knockout but that eryBI knockout was not sufficient to block isoflavone metabolism in S. erythraea.
Fermalogic, Inc., 2201 West Campbell Park Drive, Chicago, IL 60612, USA.
Andrew R
AR
Reeves
Ramya
R
Seshadri
Igor A
IA
Brikun
William H
WH
Cernota
Melissa C
MC
Gonzalez
J Mark
JM
Weber
D000192:Actinomycetales / Q000235:genetics* / Q000378:metabolism*; D001426:Bacterial Proteins / Q000235:genetics*; D001711:Biotransformation; D004917:Erythromycin / Q000096:biosynthesis*; D017353:Gene Deletion; D007529:Isoflavones / Q000378:metabolism*
D001426:Bacterial Proteins; D007529:Isoflavones; D004917:Erythromycin